Company Overview
Snapshot
Founded in November 2018, KinBio operates with 11–50 employees. The company ceased operations in January 2025.
Business overview
KinBio, a subsidiary of Hong Kong-based Gencor Pacific, specializes in the research, development, manufacturing, and global commercialization of biosimilars and biologics. The company focuses on developing generic versions of complex drugs and high-quality biosimilars to treat and prevent diseases across therapeutic areas such as CNS, inflammation, oncology, and osteoporosis. KinBio operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, serving the B2B market.
Strategic signal
In January 2019, KinBio's parent company, Gencor Pacific, acquired InSight Biopharmaceuticals for $2.5 million. This acquisition, which occurred through KinBio, provided Gencor Pacific with InSight's intellectual property and assets related to complex generic drugs and biosimilars, despite InSight facing prior financial difficulties and a liquidation petition. This event signaled KinBio's strategic role in expanding Gencor Pacific's pharmaceutical portfolio and market presence in the biosimilars and biologics space.
Log in to access full profile ›Company Intelligence Q&A
- What is KinBio's operational status?
- KinBio ceased to operate in January 2025.
- When was KinBio founded?
- KinBio was founded in November 2018.
- What was a significant acquisition involving KinBio?
- In January 2019, KinBio's parent company, Gencor Pacific Ltd., acquired InSight Biopharmaceuticals Ltd. for $2.5 million. This acquisition included InSight's intellectual property and assets for developing complex generic drugs and biosimilars.
- What is KinBio's primary focus in the pharmaceutical industry?
- KinBio is developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars, and biologics, with a focus on therapeutic areas including CNS, inflammation, oncology, and osteoporosis.
- What is KinBio's relationship with Gencor Pacific?
- KinBio is a wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific.